Bill Text: NY A09937 | 2015-2016 | General Assembly | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Prohibits managed care providers, under the medical assistance program, from requiring prior authorization for the dispensing of buprenorphine for treatment of opioid addiction.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2016-05-10 - reported referred to ways and means [A09937 Detail]

Download: New_York-2015-A09937-Introduced.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                          9937
                   IN ASSEMBLY
                                     April 28, 2016
                                       ___________
        Introduced  by  M.  of  A.  ROSENTHAL  --  read once and referred to the
          Committee on Health
        AN ACT to amend the social services  law,  in  relation  to  prohibiting
          prior authorization for the dispensing of buprenorphine for the treat-
          ment of opioid addiction
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. Section 364-j of the social  services  law  is  amended  by
     2  adding a new subdivision 26-a to read as follows:
     3    26-a.  No  managed care provider shall require prior authorization for
     4  any prescription or renewal thereof for the dispensing of  buprenorphine
     5  which is prescribed as a treatment for opioid addiction.
     6    §  2. This act shall take effect immediately, provided that the amend-
     7  ment to section 364-j of the social services law, made by section one of
     8  this act, shall not affect the expiration and repeal  of  such  section,
     9  and shall expire and be deemed repealed therewith.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD14865-01-6
feedback